.jpg)
Newborn Genome Sequencing Screening for Early Actionable Conditions
To the Editor A recent study about newborn screening using genome sequencing for early actionable conditions highlighted the potential of early detection for actionable genetic disorders. However, genomic sequencing is a “double-edged sword,” providing substantial benefits while introducing complex challenges related to technology, ethics, and privacy.
To the Editor A recent study about newborn screening using genome sequencing for early actionable conditions highlighted the potential of early detection for actionable genetic disorders. However, genomic sequencing is a “double-edged sword,” providing substantial benefits while introducing complex challenges related to technology, ethics, and privacy.
